I

INmune Bio
D

INMB

1.64100
USD
0.03
(1.93%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
17,324
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
45,543,968
أصول ذات صلة

العنوان: INmune Bio

القطاع: الرعاية الصحية
الصناعة: Biotechnology
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.